HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei-Peng He Selected Research

Cystadenoma

11/2019High expression of AGBL2 is a novel prognostic factor of adverse outcome in patients with ovarian carcinoma.
10/2019Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma.
6/2010Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
4/2010Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei-Peng He Research Topics

Disease

6Carcinoma (Carcinomatosis)
01/2020 - 04/2010
4Cystadenoma
11/2019 - 04/2010
4Neoplasms (Cancer)
11/2019 - 04/2010
2Neoplasm Metastasis (Metastasis)
05/2022 - 09/2012
2Hepatocellular Carcinoma (Hepatoma)
01/2020 - 09/2012
1Colorectal Neoplasms (Colorectal Cancer)
10/2019
1Ovarian Neoplasms (Ovarian Cancer)
09/2012
1Ovarian Epithelial Carcinoma
02/2009

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
11/2019 - 02/2009
2Small Interfering RNA (siRNA)IBA
05/2022 - 01/2020
2DNA HelicasesIBA
01/2020 - 09/2012
2Carrier Proteins (Binding Protein)IBA
01/2020 - 09/2012
2ParaffinIBA
11/2019 - 10/2019
2Biomarkers (Surrogate Marker)IBA
09/2012 - 04/2010
1GTP-Binding Proteins (G-Protein)IBA
11/2019
1Adenosine Triphosphate (ATP)IBA
11/2019
1TubulinIBA
11/2019
1Formaldehyde (Formol)FDA Link
10/2019
1K Cl- CotransportersIBA
10/2019
1ClusterinIBA
02/2009